{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20191108",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "60799",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761136lbl.pdf",
              "date": "20191108",
              "type": "Label"
            },
            {
              "id": "60817",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761136Orig1s000ltr.pdf",
              "date": "20191112",
              "type": "Letter"
            },
            {
              "id": "61346",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761136Orig1s000TOC.html",
              "date": "20191219",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20220708",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "71531",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761136Orig1s006ltr.pdf",
              "date": "20220711",
              "type": "Letter"
            },
            {
              "id": "71535",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761136s006lbl.pdf",
              "date": "20220711",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "15",
          "submission_status": "AP",
          "submission_status_date": "20260227",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "85214",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761136Orig1s015ltr.pdf",
              "date": "20260303",
              "type": "Letter"
            },
            {
              "id": "85281",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761136s015lbl.pdf",
              "date": "20260306",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20200403",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "62441",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761136orig2lbl.pdf",
              "date": "20200406",
              "type": "Label"
            },
            {
              "id": "62444",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761136Orig2s000ltr.pdf",
              "date": "20200406",
              "type": "Letter"
            },
            {
              "id": "64881",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/761136Orig2s000TOC.html",
              "date": "20201008",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20230828",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "75314",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761136s009lbl.pdf",
              "date": "20230829",
              "type": "Label"
            },
            {
              "id": "75318",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761136Orig1s009ltr.pdf",
              "date": "20230829",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20240516",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "78492",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761136s010lbl.pdf",
              "date": "20240517",
              "type": "Label"
            },
            {
              "id": "78505",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761136Orig1s010ltr.pdf",
              "date": "20240520",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "BLA761136",
      "sponsor_name": "CELGENE CORP",
      "openfda": {
        "application_number": [
          "BLA761136"
        ],
        "brand_name": [
          "REBLOZYL"
        ],
        "generic_name": [
          "LUSPATERCEPT"
        ],
        "manufacturer_name": [
          "Celgene Corporation"
        ],
        "product_ndc": [
          "59572-711",
          "59572-775"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "LUSPATERCEPT"
        ],
        "rxcui": [
          "2262906",
          "2262911",
          "2262913",
          "2262915"
        ],
        "spl_id": [
          "769ec39a-61bd-4726-b14a-9594897baa67"
        ],
        "spl_set_id": [
          "82f4d266-3f52-41eb-86ba-0abf3cf468e8"
        ],
        "package_ndc": [
          "59572-711-01",
          "59572-775-01"
        ],
        "nui": [
          "N0000194025",
          "N0000009319"
        ],
        "pharm_class_epc": [
          "Erythroid Maturation Agent [EPC]"
        ],
        "pharm_class_pe": [
          "Increased Erythroid Cell Production [PE]"
        ],
        "unii": [
          "AQK7UBA1LS"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "REBLOZYL",
          "active_ingredients": [
            {
              "name": "LUSPATERCEPT-AAMT",
              "strength": "75MG/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "POWDER",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "REBLOZYL",
          "active_ingredients": [
            {
              "name": "LUSPATERCEPT-AAMT",
              "strength": "25MG/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "POWDER",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}